Actinic keratosis is a precancerous skin condition that occurs in 26.5% of males and 10.2% of females in the United States. Actinic keratosis is characterized by rough, scaly patches of skin caused by exposure to UV light. Individuals who do not protect their skin from sun exposure are more susceptible to actinic keratosis.
Actinic keratosis treatments often involve topical medications with active ingredients like diclofenac sodium, imiquimod, levocetirizine dihydrochloride, salicylic acid, tretinoin, and niacinamide.
SKNV offers a menu of customized medications, combining active ingredients, adjusting their potencies, and eliminating potentially harmful inactive ingredients for certain patients as determined by a healthcare provider. SKNV’s gels provide a clinically different solution for actinic keratosis, tailored to individual patient needs as determined by the prescriber.
Your prescriber will determine which SKNV actinic keratosis formulation will make a clinical difference for you.
Ask your provider about SKNV. They can determine which SKNV formulation is best for your skin and prescribe your Rx directly from their office. You can leave with the medication in hand, or have your Rx shipped directly to your home.
